Revelation Biosciences, Inc.
REVB
$1.13
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.87M | -8.91M | -8.13M | -8.46M | -14.41M |
| Total Depreciation and Amortization | 27.10K | 27.10K | 28.40K | 28.80K | 28.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 920.90K | 623.00K | 304.30K | 325.70K | 377.60K |
| Change in Net Operating Assets | 233.70K | -5.90K | -2.25M | -9.61M | -4.28M |
| Cash from Operations | -8.69M | -8.27M | -10.05M | -17.72M | -18.28M |
| Capital Expenditure | -71.90K | -- | 17.70K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -71.90K | -- | 17.70K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.21M | 12.51M | 16.20M | 10.82M | 7.43M |
| Repurchase of Common Stock | -41.20K | -41.20K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.17M | 12.47M | 16.20M | 10.82M | 7.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.41M | 4.20M | 6.17M | -6.90M | -10.85M |